
Find a Doctor

Shafeeq Ladha, MD, is a neurologist, the director of the Gregory W. Fulton ALS and Neuromuscular Disease Center, the Fulton Family Chair for Motor Neuron Disease, and a professor in the Department of Neurology at Barrow Neurological Institute.
Dr. Ladha received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with ALS and neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University. He also serves an investigator member on the Northeast ALS Consortium (NEALS) Executive Committee.
For more information or to request an appointment, please call (602) 406-6262.
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis.
Date: 08/2024
Authors: Dylan V Neel, Clara Baselga-Garriga, Molly Benson, Mackenzie Keegan, Marianne Chase, Derek D'Agostino, Kristin Drake, Jennifer Linn Hagar, Meredith Gibbons Hasenoehrl, Jennifer Kulesa-Kelley, Alex Leite, Silpa Mohapatra, Susanna Marie Portaro, Lindsay M Pothier, Jesse Rosenthal, Alexander V Sherman, Hong Yu, Alexandra McCaffrey, Doreen Ho, Sarah Luppino, Richard Bedlack, Daragh Heitzman, Senda Ajroud-Driss, Jonathan Katz, Kevin Felice, Charles Whitaker, Shafeeq Ladha, Shafeeq S. Ladha, Gustavo Alameda, Eduardo Locatelli, Irfan A Qureshi, Michael T Hotchkin, Michael R Hayden, Merit E Cudkowicz, Suma Babu, James D Berry, Sabrina Paganoni
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis.
Date: 07/2024
Authors: Michael Gilligan, Connie E Lesnick, Yong Guo, Michael J Bradshaw, Shafeeq S Ladha, Shafeeq S. Ladha, Mihaela Nowak, Maulik P Shah, John R Wittenborn, Eati Basal, Shannon Hinson, Binxia Yang, Divyanshu Dubey, John R Mills, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Date: 07/2024
Authors: Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, William Camu, Magdalena Kuzma-Kozakiewicz, Leonard H van den Berg, Raul Juntas Morales, Adriano Chio, Peter M Andersen, Pierre-Francois Pradat, Dale Lange, Philip Van Damme, Gabriele Mora, Mariusz Grudniak, Matthew Elliott, Susanne Petri, Nicholas Olney, Shafeeq Ladha, Shafeeq S. Ladha, Namita A Goyal, Thomas Meyer, Michael G Hanna, Colin Quinn, Angela Genge, Lorne Zinman, Duaa Jabari, Christen Shoesmith, Albert C Ludolph, Christoph Neuwirth, Sharon Nations, Jeremy M Shefner, Martin R Turner, Joanne Wuu, Richard Bennett, Hoang Dang, Claus Sundgreen
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial
Date: 04/2023
Authors: Priya S. Kishnani, Jordi Diaz-Manera, Antonio Toscano, Paula R. Clemens, Shafeeq Ladha, Shafeeq S. Ladha, Kenneth I. Berger, Hani Kushlaf, Volker Straub, Gerson Carvalho, Tahseen Mozaffar, Mark Roberts, Shahram Attarian, Yin-Hsiu Chien, Young-Chul Choi, John W. Day, Sevim Erdem-Ozdamar, Sergey Illarioshkin, Ozlem Goker-Alpan, Anna Kostera-Pruszczyk, Ans T. van der Ploeg, Kristina An Haack, Olivier Huynh-Ba, Swathi Tammireddy, Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Date: 06/2022
Authors: Samuel Arends, Judith Drenthen, Peter van den Bergh, Hessel Franssen, Robert D M Hadden, Badrul Islam, Satoshi Kuwabara, Ricardo C Reisin, Nortina Shahrizaila, Hiroshi Amino, Giovanni Antonini, Shahram Attarian, Claudia Balducci, Fabio Barroso, Tulio Bertorini, Davide Binda, Thomas H Brannagan, Jan Buermann, Carlos Casasnovas, Guido Cavaletti, Chi-Chao Chao, Mazen M Dimachkie, Ernesto A Fulgenzi, Giuliana Galassi, Gerardo Gutiérrez Gutiérrez, Thomas Harbo, Hans-Peter Hartung, Sung-Tsang Hsieh, Lynette Kiers, Helmar C Lehmann, Fiore Manganelli, Girolama A Marfia, Giorgia Mataluni, Julio Pardo, Yann Péréon, Yusuf A Rajabally, Lucio Santoro, Yukari Sekiguchi, Beth Stein, Mark Stettner, Antonino Uncini, Christine Verboon, Camiel Verhamme, Michal Vytopil, Waqar Waheed, Min Wang, Sasha Zivkovic, Bart C Jacobs, David R Cornblath, Shafeeq S. Ladha
- English

- (602) 406-6262
- Fax: (602) 406-6261

Shafeeq Ladha, MD, is a neurologist, the director of the Gregory W. Fulton ALS and Neuromuscular Disease Center, the Fulton Family Chair for Motor Neuron Disease, and a professor in the Department of Neurology at Barrow Neurological Institute.
Dr. Ladha received his medical degree from the University of Arizona College of Medicine in Tucson in 2000. He subsequently completed his neurology residency at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, where he was a chief resident in his final year. His experience treating patients with ALS and neuromuscular disorders during these years prompted him to seek subspecialty training in neuromuscular medicine.
Dr. Ladha completed a fellowship in neuromuscular disorders and peripheral nerve diseases at Mayo Clinic in Rochester, Minnesota in 2005. During this time he also became proficient at analyzing and interpreting nerve biopsies. In 2006, he completed another fellowship at Mayo Clinic in Scottsdale, Arizona in clinical neurophysiology and electromyography, where he learned common and specialized neurophysiologic techniques such as single fiber EMG and repetitive nerve stimulation.
Dr. Ladha returned to Barrow in 2007 as the director of the Barrow MDA Clinic and eventually opened the AANEM-accredited Barrow EMG laboratory. He holds faculty positions at both the University of Arizona College of Medicine and Creighton University. He also serves an investigator member on the Northeast ALS Consortium (NEALS) Executive Committee.
For more information or to request an appointment, please call (602) 406-6262.

- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, Mayo Clinic (Rochester), Neuromuscular Disorders and Peripheral Nerve Diseases, 2005-2006
- Fellowship, Mayo Clinic (Scottsdale), Clinical Neurophysiology and EMG, 2004-2005
- Residency, Barrow Neurological Institute, Neurology, 2001-2004
- Internship, 2000-2001
- MD, University of Arizona College of Medicine, 2000
- BS, University of Notre Dame, 1996
- Fellow Member, American Association of Neuromuscular and Electrodiagnostic Medicine
- American Clinical Neurophysiology Society
- ALS Research Group
- Northeast ALS Consortium
- Peripheral Nerve Society
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis.
Date: 08/2024
Authors: Dylan V Neel, Clara Baselga-Garriga, Molly Benson, Mackenzie Keegan, Marianne Chase, Derek D'Agostino, Kristin Drake, Jennifer Linn Hagar, Meredith Gibbons Hasenoehrl, Jennifer Kulesa-Kelley, Alex Leite, Silpa Mohapatra, Susanna Marie Portaro, Lindsay M Pothier, Jesse Rosenthal, Alexander V Sherman, Hong Yu, Alexandra McCaffrey, Doreen Ho, Sarah Luppino, Richard Bedlack, Daragh Heitzman, Senda Ajroud-Driss, Jonathan Katz, Kevin Felice, Charles Whitaker, Shafeeq Ladha, Shafeeq S. Ladha, Gustavo Alameda, Eduardo Locatelli, Irfan A Qureshi, Michael T Hotchkin, Michael R Hayden, Merit E Cudkowicz, Suma Babu, James D Berry, Sabrina Paganoni
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis.
Date: 07/2024
Authors: Michael Gilligan, Connie E Lesnick, Yong Guo, Michael J Bradshaw, Shafeeq S Ladha, Shafeeq S. Ladha, Mihaela Nowak, Maulik P Shah, John R Wittenborn, Eati Basal, Shannon Hinson, Binxia Yang, Divyanshu Dubey, John R Mills, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Date: 07/2024
Authors: Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, William Camu, Magdalena Kuzma-Kozakiewicz, Leonard H van den Berg, Raul Juntas Morales, Adriano Chio, Peter M Andersen, Pierre-Francois Pradat, Dale Lange, Philip Van Damme, Gabriele Mora, Mariusz Grudniak, Matthew Elliott, Susanne Petri, Nicholas Olney, Shafeeq Ladha, Shafeeq S. Ladha, Namita A Goyal, Thomas Meyer, Michael G Hanna, Colin Quinn, Angela Genge, Lorne Zinman, Duaa Jabari, Christen Shoesmith, Albert C Ludolph, Christoph Neuwirth, Sharon Nations, Jeremy M Shefner, Martin R Turner, Joanne Wuu, Richard Bennett, Hoang Dang, Claus Sundgreen
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial
Date: 04/2023
Authors: Priya S. Kishnani, Jordi Diaz-Manera, Antonio Toscano, Paula R. Clemens, Shafeeq Ladha, Shafeeq S. Ladha, Kenneth I. Berger, Hani Kushlaf, Volker Straub, Gerson Carvalho, Tahseen Mozaffar, Mark Roberts, Shahram Attarian, Yin-Hsiu Chien, Young-Chul Choi, John W. Day, Sevim Erdem-Ozdamar, Sergey Illarioshkin, Ozlem Goker-Alpan, Anna Kostera-Pruszczyk, Ans T. van der Ploeg, Kristina An Haack, Olivier Huynh-Ba, Swathi Tammireddy, Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Date: 06/2022
Authors: Samuel Arends, Judith Drenthen, Peter van den Bergh, Hessel Franssen, Robert D M Hadden, Badrul Islam, Satoshi Kuwabara, Ricardo C Reisin, Nortina Shahrizaila, Hiroshi Amino, Giovanni Antonini, Shahram Attarian, Claudia Balducci, Fabio Barroso, Tulio Bertorini, Davide Binda, Thomas H Brannagan, Jan Buermann, Carlos Casasnovas, Guido Cavaletti, Chi-Chao Chao, Mazen M Dimachkie, Ernesto A Fulgenzi, Giuliana Galassi, Gerardo Gutiérrez Gutiérrez, Thomas Harbo, Hans-Peter Hartung, Sung-Tsang Hsieh, Lynette Kiers, Helmar C Lehmann, Fiore Manganelli, Girolama A Marfia, Giorgia Mataluni, Julio Pardo, Yann Péréon, Yusuf A Rajabally, Lucio Santoro, Yukari Sekiguchi, Beth Stein, Mark Stettner, Antonino Uncini, Christine Verboon, Camiel Verhamme, Michal Vytopil, Waqar Waheed, Min Wang, Sasha Zivkovic, Bart C Jacobs, David R Cornblath, Shafeeq S. Ladha
- English